{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:49:12Z","timestamp":1789148952595,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1558-3","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:48:40Z","timestamp":1525308520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities"],"prefix":"10.1186","volume":"20","author":[{"given":"Mengying","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasvinder A.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony R.","family":"Merriman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo L.","family":"Gaffo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo de","family":"los Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"issue":"1","key":"1558_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/ar1907","volume":"8","author":"KG Saag","year":"2006","unstructured":"Saag KG, Choi H. Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther. 2006; 8(1):2.","journal-title":"Arthritis Res Ther"},{"issue":"82","key":"1558_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jbspin.2015.01.002","volume":"3","author":"T Bardin","year":"2015","unstructured":"Bardin T. Hyperuricemia starts at 360 micromoles (6 mg\/dl). Joint Bone Spine. 2015; 3(82):141\u20133.","journal-title":"Joint Bone Spine"},{"issue":"1","key":"1558_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/art.22466","volume":"57","author":"HK Choi","year":"2007","unstructured":"Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Care Res. 2007; 57(1):109\u201315.","journal-title":"Arthritis Care Res"},{"issue":"10","key":"1558_CR4","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1093\/rheumatology\/ken305","volume":"47","author":"H Choi","year":"2008","unstructured":"Choi H, De Vera M, Krishnan E. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology. 2008; 47(10):1567\u20131570.","journal-title":"Rheumatology"},{"issue":"7","key":"1558_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","volume":"125","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the us general population: NHANES 2007\u20132008. Am J Med. 2012; 125(7):679\u201387.","journal-title":"Am J Med"},{"issue":"8","key":"1558_CR6","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","volume":"116","author":"HK Choi","year":"2007","unstructured":"Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007; 116(8):894\u2013900.","journal-title":"Circulation"},{"issue":"1","key":"1558_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/acr.21791","volume":"65","author":"SP Juraschek","year":"2013","unstructured":"Juraschek SP, Miller ER, Gelber AC. Body mass index, obesity, and prevalent gout in the United States in 1988\u20131994 and 2007\u20132010. Arthritis Care Res. 2013; 65(1):127\u201332.","journal-title":"Arthritis Care Res"},{"issue":"10","key":"1558_CR8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1751-7176.2012.00674.x","volume":"14","author":"MA McAdams-DeMarco","year":"2012","unstructured":"McAdams-DeMarco MA, Maynard JW, Baer AN, Coresh J. Hypertension and the risk of incident gout in a population-based study: the Atherosclerosis Risk in Communities cohort. J Clin Hypertens. 2012; 14(10):675\u20139.","journal-title":"J Clin Hypertens"},{"issue":"5","key":"1558_CR9","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/aje\/kwt299","volume":"179","author":"JW Maynard","year":"2013","unstructured":"Maynard JW, McAdams-DeMarco MA, Law A, Kao L, Gelber AC, Coresh J, Baer AN. Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities study. Am J Epidemiol. 2013; 179(5):576\u201383.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1558_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/acr.20344","volume":"63","author":"PC Grayson","year":"2011","unstructured":"Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res. 2011; 63(1):102\u201310.","journal-title":"Arthritis Care Res"},{"issue":"7","key":"1558_CR11","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1161\/STR.0b013e3182213e24","volume":"42","author":"S Cruz-Flores","year":"2011","unstructured":"Cruz-Flores S, Rabinstein A, Biller J, Elkind MS, Griffith P, Gorelick PB, Howard G, Leira EC, Morgenstern LB, Ovbiagele B, et al.Racial-ethnic disparities in stroke care: the American experience. Stroke. 2011; 42(7):2091\u2013116.","journal-title":"Stroke"},{"key":"1558_CR12","unstructured":"Atherosclerosis Risk in Communities Study description. https:\/\/www2.cscc.unc.edu\/aric\/desc. Accesssed 05 Apr 2018."},{"issue":"1","key":"1558_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3899\/jrheum.100418","volume":"38","author":"MA McAdams","year":"2011","unstructured":"McAdams MA, Maynard JW, Baer AN, K\u00f6ttgen A, Clipp S, Coresh J, Gelber AC. Reliability and sensitivity of the self-report of physician-diagnosed gout in the Campaign Against Cancer and Heart Disease and the Atherosclerosis Risk in the Community cohorts. J Rheumatol. 2011; 38(1):135\u201341.","journal-title":"J Rheumatol"},{"issue":"5","key":"1558_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/art.1780380508","volume":"38","author":"MC Hochberg","year":"1995","unstructured":"Hochberg MC, Thomas J, Johniene Thomas D, Mead L, Levine DM, Klag MJ. Racial differences in the incidence of gout. Arthritis Rheumatol. 1995; 38(5):628\u201332.","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"1558_CR15","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1002\/art.22014","volume":"54","author":"E Krishnan","year":"2006","unstructured":"Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheumatol. 2006; 54(8):2688\u201396.","journal-title":"Arthritis Rheumatol"},{"issue":"13","key":"1558_CR16","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1001\/archinte.1997.00440340060005","volume":"157","author":"AC Gelber","year":"1997","unstructured":"Gelber AC, Klag MJ, Mead LA, Thomas J, Thomas DJ, Pearson TA, Hochberg MC. Gout and risk for subsequent coronary heart disease: the Meharry-Hopkins Study. Arch Intern Med. 1997; 157(13):1436\u201340.","journal-title":"Arch Intern Med"},{"key":"1558_CR17","first-page":"155A","volume":"11","author":"A Levey","year":"2000","unstructured":"Levey A. A simplified equation to predict glomerular filtration rate from serum creatinine [abstract]. J Am Soc Nephrol. 2000; 11:155A.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1558_CR18","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1053\/ajkd.2002.32765","volume":"39","author":"J Coresh","year":"2002","unstructured":"Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, Levey AS. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002; 39(5):920\u20139.","journal-title":"Am J Kidney Dis"},{"key":"1558_CR19","unstructured":"World Health Organization. BMI classification. http:\/\/apps.who.int\/bmi\/index.jsp?introPage=intro\\_3.html. Accesssed 05 Apr 2018."},{"key":"1558_CR20","unstructured":"American Heart Association. SBP, glucose, cholesterol category. \n                    http:\/\/www.heart.org\/\n                    \n                  . Accesssed 05 Apr 2018."},{"key":"1558_CR21","unstructured":"National Kidney Foundation. eGFR category. https:\/\/www.kidney.org\/atoz\/content\/gfr. Accesssed 05 Apr 2018."},{"key":"1558_CR22","unstructured":"National Institutes of Health. Conversion ratio for HDL, LDL, triglycerides. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK83505\/. Accesssed 05 Apr 2018."},{"key":"1558_CR23","unstructured":"Joslin Diabetes Center. Conversion Ratio for Glucose. \n                    http:\/\/www.joslin.org\/\n                    \n                  . Accesssed 05 Apr 2018."},{"key":"1558_CR24","volume-title":"Selected papers of Hirotugu Akaike","author":"H Akaike","year":"1998","unstructured":"Akaike H. Information theory and an extension of the maximum likelihood principle. In: Selected papers of Hirotugu Akaike. Berlin: Springer: 1998. p. 199\u2013213."},{"issue":"2","key":"1558_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1214\/aos\/1176344136","volume":"6","author":"G Schwarz","year":"1978","unstructured":"Schwarz G, et al.Estimating the dimension of a model. Ann Stat. 1978; 6(2):461\u20134.","journal-title":"Ann Stat"},{"key":"1558_CR26","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2016","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2016. R Foundation for Statistical Computing. https:\/\/www.r-project.org. https:\/\/CRAN.R-project.org\/package=fmsb. Accesssed 05 Apr 2018"},{"key":"1558_CR27","unstructured":"Nakazawa M. fmsb: functions for medical statistics book with some demographic data. R package version 0.6.0. 2017. \n                    https:\/\/www.r-project.org\n                    \n                  . Accesssed 05 Apr 2018."},{"issue":"7","key":"1558_CR28","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/archinte.158.7.741","volume":"158","author":"PJ Savage","year":"1998","unstructured":"Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, Cohen J, Davis BR, Frost P, Smith W, et al.Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the systolic hypertension in the elderly program. Arch Intern Med. 1998; 158(7):741\u201351.","journal-title":"Arch Intern Med"},{"issue":"1","key":"1558_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1161\/01.HYP.0000150784.92944.9a","volume":"45","author":"J Sundstr\u00f6m","year":"2005","unstructured":"Sundstr\u00f6m J, Sullivan L, D\u2019Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005; 45(1):28\u201333.","journal-title":"Hypertension"},{"issue":"2","key":"1558_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/MAJ.0000000000000308","volume":"348","author":"DT Lackland","year":"2014","unstructured":"Lackland DT. Racial differences in hypertension: implications for high blood pressure management. Am J Med Sci. 2014; 348(2):135.","journal-title":"Am J Med Sci"},{"issue":"5","key":"1558_CR31","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/hy1101.092839","volume":"38","author":"M Mazzali","year":"2001","unstructured":"Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001; 38(5):1101\u20136.","journal-title":"Hypertension"},{"issue":"9","key":"1558_CR32","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/ndt\/gft029","volume":"28","author":"RJ Johnson","year":"2013","unstructured":"Johnson RJ, Nakagawa T, Jalal D, S\u00e1nchez-Lozada LG, Kang DH, Ritz E. Uric acid and chronic kidney disease: which is chasing which?. Nephrol Dial Transplant. 2013; 28(9):2221\u2013228.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"1558_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10654-007-9132-3","volume":"22","author":"W Rathmann","year":"2007","unstructured":"Rathmann W, Haastert B, Icks A, Giani G, Roseman JM. Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA Study. Eur J Epidemiol. 2007; 22(7):439\u201345.","journal-title":"Eur J Epidemiol"},{"key":"1558_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/1471-2474-14-347","volume":"14","author":"MA McAdams-DeMarco","year":"2013","unstructured":"McAdams-DeMarco MA, Law A, Maynard JW, Coresh J, Baer AN. Risk factors for incident hyperuricemia during mid-adulthood in African American and white men and women enrolled in the ARIC cohort study. BMC Musculoskelet Disord. 2013; 14:347.","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"1558_CR35","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1136\/ard.2007.081604","volume":"67","author":"JA Singh","year":"2008","unstructured":"Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in us veterans. Ann Rheum Dis. 2008; 67(9):1310\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1558_CR36","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/rheumatology\/ket265","volume":"52","author":"P Chandratre","year":"2013","unstructured":"Chandratre P, Roddy E, Clarson L, Richardson J, Hider SL, Mallen CD. Health-related quality of life in gout: a systematic review. Rheumatology. 2013; 52(11):2031\u201340.","journal-title":"Rheumatology"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1558-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1558-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1558-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T23:10:58Z","timestamp":1556838658000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1558-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1558"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1558-3","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,3]]},"assertion":[{"value":"6 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study involves secondary data analysis of de-identified data. There were no individual participants in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JAS has received research grants from Takeda and Savient Pharmaceuticals and consultant\u2019s fees from Savient Pharmaceuticals, Takeda, Regeneron, Merz, Iroko, Bioiberica, Crealta\/Horizon, Allergan Pharmaceuticals, WebMD, UBM LLC, Medscape, Fidia Pharmaceuticals, and the American College of Rheumatology. JAS serves as the principal investigator for an investigator-initiated study funded by Horizon Pharmaceuticals through a grant to DINORA, Inc., a 501(c)(3) entity. JAS is a member of the executive board of OMERACT, an organization that develops outcome measures in rheumatology and receives arm\u2019s-length funding from 36 companies; is a member of the American College of Rheumatology\u2019s (ACR\u2019s) Annual Meeting Planning Committee (AMPC); is chair of the ACR Meet-the-Professor Workshop and Study Group Subcommittee; and is a member of the Veterans Affairs Rheumatology Field Advisory Committee. JAS is the editor and director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. TRM declares receiving grant funding from Ardea Biosciences and Ironwood Pharmaceuticals. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"90"}}